Within just three years, Vaxinano has developed versatile mucosal prophylactic or therapeutic vaccines against zoonosis ...

Most of the travelers who contracted malaria in Asia had visited India. One of our patients with mucosal leishmaniasis was admitted 5 years after the end of his trip. This case highlights the ...

Within just three years, Vaxinano has developed versatile mucosal prophylactic or therapeutic vaccines against zoonosis (leishmaniasis, toxoplasmosis, colibacillosis, vibriosis), collaborating ...

The leishmaniases broadly fall into two categories: tegumentary leishmaniases (TL), affecting the skin and mucosa, and visceral leishmaniasis (VL), targeting the internal organs. 3,4 Within TL ...

In less than three years, Vaxinano has developed versatile mucosal vaccines, both prophylactic and therapeutic, against zoonotic diseases such as leishmaniasis, toxoplasmosis and colibacillosis to ...

Vaxinano, a pioneering biotech company specializing in the development of prophylactic and therapeutic nasal vaccines, has successfully raised ?6 million in a funding round. The round was led by TCD ...

The researchers set out to investigate the effects of multiple mRNA vaccines on mucosal immunity, referring to mucous membranes such as the ones on the inside of our noses. Specifically ...

Despite the disparate findings, editorial writers say mucosal immunization could go further than current intramuscular COVID-19 vaccines by preventing infection altogether, disrupting viral ...

This ailment affects children, young people, adults and the elderly, leishmaniasis is a disease that has greatly affected the inhabitants of the Caripe municipality, north of the Monagas State. ¡Únete ...